Reduced Mortality and Severe Disability Rates in the SENTIS Trial

Assessment of Additional Endpoints for Trials in Acute Stroke – What, When, Where, in Who?

(2015) Peter D. Schellinger et al.   International Journal of Stroke

Safety and Feasibility of NeuroFlo Use in Eight- to 24–Hour Ischemic Stroke Patients

(2012) M. D. Hammer et al.   International Journal of Stroke

Statistical Analysis of the Primary Outcome in Acute Stroke Trials

(2012) Philip M.W. Bath et al.   STROKE

Contemporary Outcome Measures in Acute Stroke Research

(2012) Kennedy R. Lees et al.   STROKE

Refining the Definition of the Malignant Profile

(2011) Michael Mlynash et al.   STROKE

Safety and Feasibility of Collateral Blood Flow Augmentation After Intravenous Thrombolysis

(2011) Derek J. Emery et al.   STROKE

Partial Aortic Occlusion for Cerebral Perfusion Augmentation

(2011) Ashfaq Shuaib et al.   STROKE

Partial Occlusion of the Descending Aorta Increases Cerebral Blood Flow in a Nonstroke Porcine Model

(2009) Maxim Hammer et al.   CEREBROVASCULAR DISEASES

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

(2008) Stephen M Davis et al.   LANCET NEUROLOGY

Aortic occlusion for cerebral ischemia: From theory to practice

(2008) David S. Liebeskind   Current Cardiology Reports